OverviewSuggest Edit
BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development. Its platform empowers scientists to decipher the complex code underlying human biology and find new ways to treat disease.
| Type | Private | |
| Founded | 2013 | |
| HQ | London, GB | Map |
| Website | benevolent.com | |
| Employee Ratings | More |
Recent NewsAll News
- BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial
- BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target
- How BenevolentAI bounced back from a $1 billion loss
- COVID-19 update: Possible cure found by BenevolentAI
Key People/Management at BenevolentAI
Ken Mulvany
Founder and Chairman
Joanna Shields
CEO
Ivan Griffin
COO & Co-Founder
Anne Phelan
CSO
Ben Medlock
CTO
Rob Quinn
CFO
BenevolentAI Office Locations
BenevolentAI has offices in London, Babraham and Antwerpen
London, GB (HQ)
4-8 Maple St, Bloomsbury
Babraham, GB
Babraham Hall House
Antwerpen, BE
Franklin Rooseveltplaats 12
BenevolentAI Financials and Metrics
Summary Metrics
Founding Date | 2013 |
BenevolentAI total Funding | $305 m |
BenevolentAI latest funding size | $90 m |
Time since last funding | 2 years ago |
BenevolentAI investors | Temasek Holdings, Lundbeck, Woodford Investment Management, Lansdowne Partners, Upsher Smith Laboratories |
BenevolentAI's latest funding round in September 2019 was reported to be $90 m. In total, BenevolentAI has raised $305 m. BenevolentAI's latest valuation is reported to be $1 b.
BenevolentAI Revenue
BenevolentAI's revenue was reported to be £6.83 m in FY, 2018 which is a 164.1% increase from the previous period.
| GBP | |
|---|---|
Revenue (FY, 2018) | 6.8m |
Revenue growth (FY, 2017 - FY, 2018), % | 164.1% |
Gross profit (FY, 2018) | 6.8m |
Gross profit margin (FY, 2018), % | 100% |
Net income (FY, 2018) | (26.9m) |
EBIT (FY, 2018) | (32.6m) |
Market valuation | 1.0b |
Cash (31-Dec-2018) | 32.5m |
| GBP | FY, 2017 |
|---|---|
Revenue/Employee | 42.3k |
Financial Leverage | 0.6 x |
BenevolentAI Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| BenevolentAI Cambridge Limited | February 21, 2018 | |
| BenBio GK | ||
| BenevolentAI Bio Limited | ||
| BenevolentAI Energy Limited | ||
| BenevolentAI Technology Inc | ||
| BenevolentAI Technology Limited |
BenevolentAI Revenue Breakdown
BenevolentAI revenue breakdown by business segment: 91.4% from License Revenue and 8.6% from Rendering of Services
BenevolentAI revenue breakdown by geographic segment: 90.3% from Europe, 8.6% from USA and 1.2% from Other
BenevolentAI Cybersecurity Score
BenevolentAI Online and Social Media Presence
6.81k Twitter followers
BenevolentAI has 6.81k Twitter Followers. The number of followers has increased 1.7% month over month and increased 3.3% quarter over quarter
BenevolentAI's Trends
Twitter Engagement Stats for @benevolent_ai
2.9k
Tweets
583
Following
6.8k
Followers
60
Tweets last 30 days
2.5
Avg. likes per Tweet
96.7%
Tweets with engagement
BenevolentAI News and Updates
February 11, 2021
BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial
LONDON, Feb. 11, 2021 /PRNewswire/ -- BenevolentAI, a leader in the application of AI and machine learning in drug discovery and development, announced dosing of the first patient in its randomised first-in-human clinical trial of BEN-2293, a molecule designed and developed by...
January 27, 2021
BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target
LONDON, Jan. 27, 2021 /PRNewswire/ -- BenevolentAI today announced that the biopharmaceutical company AstraZeneca has selected a novel chronic kidney disease (CKD) target to advance to its drug development portfolio, making it the first AI-generated target from the collaboration to enter...
May 05, 2020
How BenevolentAI bounced back from a $1 billion loss
When London tech startup BenevolentAI secured a $90 million (£68 million) cash injection from Singaporean sovereign fund Temasek in September 2019, the deal valued the business at $1 billion. Not bad for a six-year-old company whose ambition to dramatically change the way drugs are discovered and de…
May 04, 2020
COVID-19 update: Possible cure found by BenevolentAI
By using high-end BenevolentAI technologies, a possible treatment was found and pinpointed in such a speedy manner that shocked the company that makes the said drug, and as well as the other doctors who had spent years into researching about the effects on other viruses.
April 18, 2020
In the time of Covid pandemic, AI comes to the rescue
An Artificial Intelligence (AI) software developed by BenevolentAI, a London-based startup has created a super search engine that combines the data from the drug industry data and chunks of new information garnered from scientific research papers.
April 15, 2020
AI could cure coronavirus: London-based BenevolentAI enters clinical trials
In this regard, BenevolentAI, a London-based company that creates and applies AI and machine learning to transform the way medicines are discovered and developed has announced that baricitinib, which it identified this year as a potential treatment for COVID-19, will be entering late-stage phase 3 c…
BenevolentAI Blogs
April 11, 2020
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters clinical testing
In response to the global coronavirus pandemic, BenevolentAI announced that
baricitinib is entering clinical testing as a potential treatment for
COVID-19. BenevolentAI identified the drug in recent research by using
artificial intelligence and machine learning. The trial by Eli Lilly will
inves…
March 17, 2020
Future Fifty: joining forces to drive forward positive change
BenevolentAI today announced it has been selected for Tech Nation’s 2020
Future Fifty cohort. In this blog, BenevolentAI’s CEO Joanna Shields
reflects on how joining forces with like minded industry experts can serve
as a powerful vehicle for transformation.
March 11, 2020
International Women’s Day: A Conversation with Four Female Colleagues
For International Women’s Day we hosted a fireside chat in London with four
of our inspiring female colleagues to learn more about their experiences,
successes and the barriers or challenges they've faced as a woman in a
largely male dominated industry.
March 08, 2020
How historically neglecting sex differences have impacted women’s health.
Sex differences have historically been neglected in clinical research,
design and practice. To mark International Women’s Day, we explored the
implications of this ‘one size fits all’ approach to medical research and
treatment for women’s health.
March 08, 2020
How historically neglecting sex differences has impacted women’s health
Sex differences have historically been neglected in clinical research,
design and practice. To mark International Women’s Day, we explored the
implications of this ‘one size fits all’ approach to medical research and
treatment for women’s health.
March 03, 2020
Medical data: the key to unlocking the true potential of AI in healthcare
The biomedical research data-gap risks worsening health inequality, and
will be exacerbated in the age of artificial intelligence if action is not
taken now. In a recent panel at Benevolent, technology and healthcare
experts discussed the data diversity issue and proposed solutions.
BenevolentAI Frequently Asked Questions
When was BenevolentAI founded?
BenevolentAI was founded in 2013.
Who are BenevolentAI key executives?
BenevolentAI's key executives are Ken Mulvany, Joanna Shields and Ivan Griffin.
How many employees does BenevolentAI have?
BenevolentAI has 281 employees.
What is BenevolentAI revenue?
Latest BenevolentAI annual revenue is £6.8 m.
What is BenevolentAI revenue per employee?
Latest BenevolentAI revenue per employee is £24.3 k.
Who are BenevolentAI competitors?
Competitors of BenevolentAI include LabGenius, SOM Biotech and Paige.
Where is BenevolentAI headquarters?
BenevolentAI headquarters is located at 4-8 Maple St, Bloomsbury, London.
Where are BenevolentAI offices?
BenevolentAI has offices in London, Babraham and Antwerpen.
How many offices does BenevolentAI have?
BenevolentAI has 4 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies